A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
Docetaxel Combined With Carboplatin Plus Anlotinib as First Line Treatment in NSCLC
- Status
- UNKNOWN
- Phase
- PHASE4
Evaluation of PLD Combined With Carboplatin Versus Paclitaxel Plus Carboplatin in the First-line Treatment of Epithelial Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE4
Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
To Evaluate the Efficacy and Safety of SCT510 in the Treatment of Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Safety and Efficacy of Tisotumab Vedotin Monotherapy & in Combination With Other Cancer Agents in Subjects With Cervical Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
European Trial on Enhanced DNA Repair Inhibition in Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
APG-115 in Salivary Gland Cancer Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Phase II Study of SHR-1210(Anti-PD-1 Antibody) Combination With Apatinib Versus Pemetrexed and Carboplatin in Subjects With KRAS Mutant Stage IV Non-squamous Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
An Investigational Immuno-therapy Study of Nivolumab Given After Surgery in Non-Small Cell Lung Cancer (NSCLC) Participants With Minimal Residual Disease
- Status
- WITHDRAWN
- Phase
- PHASE2
Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE3
Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer
- Status
- UNKNOWN
- Phase
- NA
Safety and Efficacy of Transient Opening of the Blood-brain Barrier (BBB) With the SonoCloud-9
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)
- Status
- COMPLETED
- Phase
- PHASE3
Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Trial of Atezolizumab Plus Chemotherapy After Progression on PD-1 or PD-L1 in Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Acalabrutinib Plus RICE for Relapsed/Refractory DLBCL
- Status
- UNKNOWN
- Phase
- PHASE2
Apatinib Combined With Paclitaxel and Carbopatin Intensive Regimen in Neoadjuvant Therapy for Locally Advanced Triple-negative Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2